Ansaripour, A., Thio, H.B., Maessen, R. & Redekop, W.K. (2017). The cost–effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis. Journal of comparative effectiveness research. doi: 10.2217/cer-2017-0007

Bekker – Grob, E.W. de, Berlin, C., Levitan, B., Raza, K., Christoforidi, K., Cleemput, I., Pelouchova, J., Enzmann, H., Cook, N. & Hansson, M.G. (2017). Giving patients preferences a voice in medical treatment life cycle: The PREFER public-private project. The patient: Patient-Centered Outcomes Research, 10 (3), 263-266. doi: 10.1007/s40271-017-0222-3

Benning, T.M., Alayli-Goebbels, F.G., Aarts, M., Stolk, E.A., Evers, S.M.A.A., de WIt, G.A., Prenger, R. & Braakman-Jansen, L.M.A. (2017). Exploring Outcomes to Consider in Economic Evaluations of Health Promotion Programs: What Non-Health Outcomes Matter Most? Bmc Health Services Research, 15 (266), 1-8. doi: 10.1186/s12913-015-0908-y

Blommestein, H.M., Uyl-de Groot, C.A. de & Zweegman, S. (2017). De econoom en de hematoloog: kosten, effecten en verantwoorde toegang tot zorg. Nederlands Tijdschrift voor Hematologie, 14 (6), 273-281.

Büyükkaramikli, N., Blommestein, H.M., Riemsma, R., Armstrong, N., Clay, F.J., Ross, J., Worthy, G., Severens, J.L., Kleijnen, J. & Al, M.J. (2017). Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics (Print).

Büyükkaramikli, N.C., Groot, S. de, Fayter, D., Wolff, R., Armstrong, N., Stirk, L., Worthy, G., Albuquerque de Almeida, F.G., Kleijnen, J. & Al, M.J. (2017). Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics (Print). doi: 10.1007/s40273-017-0581-6

Camejo, R.R., Miraldo, M. & Rutten, F.F.H. (2017). Cost-Effectiveness and Dynamic Efficiency: Does the Solution Lie Within? Value in Health, 20 (2), 240-243. doi: 10.1016/j.jval.2016.12.004

Ceornodolea, A.D., Bal, R.A. & Severens, J.L. (2017). Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries. Stroke:8593207. doi: 10.1155/2017/8593207

Corro Ramos, I., Versteegh, M.M., Koenders, J.M., Linssen, G.C., Meeder, J. & Rutten – van Molken, M.P.M.H. (2017). Cost-Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines. Value in Health. doi: 10.1016/j.jval.2017.05.013

Determann, D., Lambooij, M.S., Steyerberg, E.W., Bekker – Grob, E.W. de & Wit, G.A. (2017). Impact of Survey Administration Mode on the Results of a Health-Related Discrete Choice Experiment: Online and Paper Comparison. Value in Health, 20 (7), 953-960. doi: 10.1016/j.jval.2017.02.007

Determann, D., Lambooij, M.S., Gyrd-Hansen, D., Bekker – Grob, E.W. de, Steyerberg, E.W., Heldoorn, M., Pedersen, L. & Wit, G.A. (2017). Personal health records in the Netherlands: potential user preferences quantified by a discrete choice experiment. Journal of the American Medical Informatics Association, 24 (3), 529-536. doi: 10.1093/jamia/ocw158

Goorden, M., van der Feltz-Cornelis, C.M., Steenbergen-Weijenburg, K.M. van, Horn, E.K., Beekman, A.T.F. & Hakkaart – van Roijen, L. (2017). Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC-DIM). Neuropsychiatric Disease and Treatment, 2017:13, 1881-1893. doi: 10.2147/NDT.S134008

Goossens, L.M.A., Molken, M.P.M.H. van, Boland, M.R.S., Donkers, B., Jonker, M.F., Slok, A.H.M., Salome, Ph.L., van Schayck, C.P., in ‘t Veen, J.C.C.M. & Stolk, E.A. (2017). ABC Index: quantifying experienced burden of COPD in a discrete choice experiment and predicting costs. BMJ Open, 7 (12). doi: 10.1136/bmjopen-2017-017831.

Grustam, A., Vrijhoef, H., Koymans, R., Hukal, P. & Severens, J.L. (2017). Assessment of a Business-to-Consumer (B2C) model for Telemonitoring patients with Chronic Heart Failure (CHF). BMC Medical Informatics and Decision Making, 17 (1), 145. doi: 10.1186/s12911-017-0541-2

Grustam, A., Vrijhoef, H., Cordella, A., Koymans, R. & Severens, J.L. (2017). Care coordination in a business-to-business and a business-to-consumer model for telemonitoring patients with chronic diseases. International Journal of Career Management, 20 (4), 135-147. doi: 10.1177/2053434517747908

Hermans, J., Reijman, M., Goossens, L.M.A., Verburg, H., Bierma-Zeinstra, S.M.A. & Koopmanschap, M.A. (2017). A cost utility analysis of high molecular weight hyaluronic acid for knee osteoarthritis in everyday clinical care. Arthritis Care & Research. doi: 10.1002/acr.23242

Hifinger, M., Hiligsmann, M., Ramiro, S., Severens, J.L., Fautrel, B., Watson, V. & Boonen, A. (2017). Patients’ preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists. Rheumatology, 56 (1). doi: 10.1093/rheumatology/kew328

Hoogendoorn, M., Feenstra, T.L., Boland, M., Briggs, A., Borg, S. ter, Jansson, S., Risebrough, N.A., Slejko, J.F. & Rutten – van Molken, M.P.M.H. (2017). Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. International Journal of COPD, 12, 3183-3194. doi: 10.2147/COPD.S142378

Houben, E., Haalen, H.G.M. van, Sparreboom, W., Overbeek, J.A., Ezendam, N.P.M., Pijnenborg, J., Severens, J.L. & Herk-Sukel, M.P.P. (2017). Chemotherapy for ovarian cancer in the Netherlands: a population-based study on treatment patterns and outcomes. Medical Oncology and tumor pharmacotherapy, 34 (4). doi: 10.1007/s12032-017-0901-x

Janse, B., Huijsman, R., Looman, W.M. & Fabbricotti, I.N. (2017). Formal and informal care for community-dwelling people over time: A comparison of integrated and usual care in the Netherlands. Health & Social Care in the Community, 1-11. doi: 10.1111/hsc.12516

Jonker, M.F., Attema, A.E., Donkers, B., Stolk, E.A. & Versteegh, M.M. (2017). Are Health State Valuations from the General Public Biased? A Test of Health State Reference Dependency Using Self-assessed Health and an Efficient Discrete Choice Experiment. Health Economics, 26 (12), 1534-1547. doi: 10.1002/hec.3445

Kanters, T.A., Stevanovic, J., Huys, I., Vulto, A.G. & Simoens, S. (2017). Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel. Frontiers in pharmacology, 8:322. doi: 10.3389/fphar.2017.00322

Kanters, T.A., Ploeg, A.T. van der, Kruijshaar, M.E., Rizopoulos, D., Redekop, W.K., Rutten – van Molken, M.P.M.H. & Hakkaart – van Roijen, L. (2017). Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease. Orphanet Journal of Rare Diseases, 12:179. doi: 10.1186/s13023-017-0731-0

Kanters, T.A., Bouwmans, C.A.M., Linden, N. van der, Tan, S.S. & Hakkaart-van Roijen, L. (2017). Update of the Dutch manual for costing studies in health care. PLoS One (print), 12. doi: 10.1371/journal.pone.0187477

Kanters, T.A. (2017). Moeilijke beslissingen vergoeding weesgeneesmiddelen. Pharmaceutisch Weekblad, 152 (50), 16-17.

Krugten, F.C.W. van, Kaddouri, M., Goorden, M., Balkom, A.J.L.M. van, Bockting, C., Peeters, F.P.M.L. & Hakkaart-van Roijen, L. (2017). Indicators of patients with major depressive disorder in need of highly specialized care: A systematic review. PLoS One (online). doi: 10.1371/journal.pone.0171659

Looman, W.M., Fabbricotti, I.N., Blom, J., Jansen, D., Lutomski, J. & Huijsman, R. (2017). Managing frailty: exploring the effectiveness of integrated primary care interventions by distinguishing subpopulations of frail older people. International Journal of Integrated Care.

Mandrik, O., Ekwunife, O.I., Zielonke, N., Meheus, F., Severens, J.L., Lhachimi, S.K. & Murillo, R. (2017). What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews. Systematic Reviews, 6 (122). doi: 10.1186/s13643-017-0510-y

Mihajlović, J., Bax, P., van Breugel, E., Blommestein, H.M., Hoogendoorn, M., Hospes, W. & Postma, M.J. (2017). Microcosting Study of Rituximab Subcutaneous Injection Versus Intravenous Infusion. Clinical Therapeutics, 39 (6), 1221-1232. doi: 10.1016/j.clinthera.2017.05.342

Ostermann, J., Brown, D.S., Bekker – Grob, E.W. de, Muhlbacher, A.C. & Reed, S.D. (2017). Preferences for Health Interventions: Improving Uptake, Adherence, and Efficiency. The patient: Patient-Centered Outcomes Research, 10 (4), 511-514. doi: 10.1007/s40271-017-0251-y

Paolucci, F., Redekop, W.K., Fouda, A. & Fiorentini, G. (2017). Decision Making and Priority Setting: The Evolving Path Towards Universal Health Coverage. Applied Health Economics and Health Policy, 15 (6), 697-706. doi: 10.1007/s40258-017-0349-3

Redekop, W.K. (2017). Mapping the dimensions of Health Policy and Technology. Health Policy and Technology, 6 (2), 121-123. doi: 10.1016/j.hlpt.2017.05.001

Redekop, W.K., Lenk, E.J., Luyendijk, M., Fitzpatrick, C., Niessen, L., Stolk, W.A., Tediosi, F., Rijnsburger, A.J., Bakker, R., Hontelez, J.A.C., Richardus, J.H., Jacobson, J., Vlas, S.J. de & Severens, J.L. (2017). The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases. PLoS Neglected Tropical Diseases (online), 11 (1):e0005289. doi: 10.1371/journal.pntd.0005289

Redekop, W.K. (2017). Personalised medicine to improve cardiovascular health. In W. French, M. Hulse & D.J. Singer (Eds.), The Hippocrates Book of the Heart (pp. 159-161). London, UK: The Hippocrates Press

Schawo, S.J., Brouwer, W.B.F. & Hakkaart – van Roijen, L. (2017). Clinicians’ Views on Therapeutic Outcomes of Systemic Interventions and on the Ability of the EQ-5D to Capture these Outcomes. Journal of Mental Health Policy and Economics, 20 (3), 131-136.

Smits, L.C., Schuurmans, M., Blom, J.W., Fabbricotti, I.N., Jansen, A., Kempen, G.I.J.M., Koopmans, R., Looman, W.M., Melis, R., Metzelthin, S.F., Moll van Charante, E., Muntinga, M., Ruikes, F., Spoorenberg, S., Suijker, J.J., Wynia, K., Gussekloo, J., De Wit, N.J. & Bleijenberg, N. (2017). Unravelling complex primary care programmes to maintain independent living in older people: a systematic overview. Journal of Clinical Epidemiology. doi: 10.1016/j.jclinepi.2017.12.013

Tabberer, M., Gonzalez-McQuire, S., Muellerova, H., Briggs, A., Rutten – van Molken, M.P.M.H., Chambers, M. & Lomas, D. (2017). Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary Disease. Medical Decision Making. doi: 10.1177/0272989X16662009

Versteegh, M.M. (2017). Vaar niet op deernis voor enkelen bij duur medicijn. NRC Handelsblad (print).

van Beurden-Tan, C.H.Y., Franken, M.G., Blommestein, H.M., Uyl-de Groot, C.A. de & Sonneveld, P. (2017). Reply to X. Armoiry et al. Journal of Clinical Oncology, 35 (25), 2976. doi: 10.1200/JCO.2017.73.7569

van der Schans, S., Goossens, L.M.A., Boland, M.R.S., Kocks, J.W., Postma, M.J., van Boven, J.F. & Rutten – van Molken, M.P.M.H. (2017). Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations. Pharmacoeconomics (Print), 35, 43-63. doi: 10.1007/s40273-016-0448-2